| Literature DB >> 28830552 |
Miguel A Velasco1, Rafael Raya2,3, Luca Muzzioli4, Daniela Morelli4, Abraham Otero3, Marco Iosa4, Febo Cincotti4, Eduardo Rocon2.
Abstract
BACKGROUND: This paper presents the preliminary results of a novel rehabilitation therapy for cervical and trunk control of children with cerebral palsy (CP) based on serious videogames and physical exercise. MATERIALS: The therapy is based on the use of the ENLAZA Interface, a head mouse based on inertial technology that will be used to control a set of serious videogames with movements of the head.Entities:
Keywords: Cerebral palsy; Cervical posture; Inertial sensors; Serious games
Mesh:
Year: 2017 PMID: 28830552 PMCID: PMC5568605 DOI: 10.1186/s12938-017-0364-5
Source DB: PubMed Journal: Biomed Eng Online ISSN: 1475-925X Impact factor: 2.819
Fig. 1Angular orientations in frontal, sagittal and transverse planes measured in two people using a head mouse: an individual with hypotonic CP (dark blue) and a non-impaired user (light blue)
Fig. 2The ENLAZA interface (Werium Solutions S.L., Spain)
Inclusion/exclusion criteria for rehabilitation therapy based on head movements and serious videogames
| Inclusion criteria | Exclusion criteria |
|---|---|
| Males and females, aged 4–21 years old | Aggressive or self-injure behavior |
| Diagnosed CP and cervical hypotonia or difficulties on head control | Involuntary movements of the head |
| Cognitive capacity and behavior appropriate to understand the tasks and follow simple instruction and active participation in the study | Cervical surgery within the previous 6 months |
| Signed written informed consent by parents or legal guardian | Inability to control the ENLAZA system during the first testing session |
| Medically stable | Severe visual limitations |
Fig. 3A training session with ENLAZA. The user has a wired IMU attached to a baseball cap and plays the game Extreme Tux Racer
Clinical scores for experimental group (p value refers to Wilcoxon signed rank test)
| Experimental group | Pre | Post | Sig. |
|---|---|---|---|
| VAS | 6.4 ± 1.1 | 7.6 ± 1.3 |
|
| GAS | 22.8 ± 0.4 | 64.3 ± 3.6 |
|
| TCMS | 19.4 ± 47.5 | 24.2 ± 17.9 |
|
| GMFM-88 | 44.4 ± 0.20 | 50.2 ± 27.8 | N.s. |
Significance: * <0.05
Clinical scores for control group (p value refers to Wilcoxon signed rank test)
| Control group | Pre | Post | Sig. |
|---|---|---|---|
| VAS | 5.4 ± 1.1 | 6.2 ± 1.3 |
|
| GAS | 24.8 ± 1.2 | 63.3 ± 5.9 |
|
| TCMS | 9.6 ± 13.2 | 10.0 ± 13.7 | N.s. |
| GMFM-88 | 23.0 ± 13.3 | 23.3 ± 13.6 | N.s. |
Significance: * <0.05
Percentage improvements in clinical scores for experimental, vs. control group (p value refers to Mann Whitney u test)
| Scale | Experimental | Control group | Sig. |
|---|---|---|---|
| VAS | 18.9 ± 6.0% | 15.2 ± 9.4% | N.s. |
| GAS | 181.3 ± 17.0% | 155.6 ± 27.9% | N.s. |
| TCMS | 27.2 ± 11.5% | 1.8 ± 4.1% |
|
| GMFM-88 | 11.5 ± 18.7% | 0.8 ± 1.77% | N.s. |
Significance: * <0.05
Fig. 4Mean and standard deviations of percentage improvements in the experimental group (dark blue) and the control group (light blue)
Fig. 5Evolution of the ROMs measured for the participant CP1.The circle represents the maximum angles measured; the star the minimum angles recorded
Fig. 6Mean values of task performance (success rate and throughput) pre- and post-intervention